Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

December 01, 1989; Volume 36,Issue 6
  • You have access
    Involvement of sulfhydryl residues in aldose reductase-inhibitor interaction.
    A Bhatnagar, S Liu, B Das and S K Srivastava
    Molecular Pharmacology December 1989, 36 (6) 825-830;
  • You have access
    Irreversible activation of phospholipase C-coupled P2Y-purinergic receptors by 3'-O-(4-benzoyl)benzoyl adenosine 5'-triphosphate.
    J L Boyer and T K Harden
    Molecular Pharmacology December 1989, 36 (6) 831-835;
  • You have access
    Spermine enhances binding to the glycine site associated with the N-methyl-D-aspartate receptor complex.
    A I Sacaan and K M Johnson
    Molecular Pharmacology December 1989, 36 (6) 836-839;
  • You have access
    Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: conserved aspartic acids play important roles in receptor function.
    C M Fraser, C D Wang, D A Robinson, J D Gocayne and J C Venter
    Molecular Pharmacology December 1989, 36 (6) 840-847;
  • You have access
    Inhibition of epidermal growth factor receptor tyrosine kinase activity in A431 human epidermoid cells following psoralen/ultraviolet light treatment.
    F H Mermelstein, T F Abidi and J D Laskin
    Molecular Pharmacology December 1989, 36 (6) 848-855;
  • You have access
    Human liver thermostable phenol sulfotransferase: photoaffinity labeling with 2-iodo-4-azidophenol.
    D M Otterness, S P Powers, L J Miller and R M Weinshilboum
    Molecular Pharmacology December 1989, 36 (6) 856-865;
  • You have access
    Model of prostaglandin-regulated cyclic AMP metabolism in intact platelets: examination of time-dependent effects on adenylate cyclase and phosphodiesterase activities.
    B Ashby
    Molecular Pharmacology December 1989, 36 (6) 866-873;
  • You have access
    Actions of pentobarbital enantiomers on nicotinic cholinergic receptors.
    S H Roth, S A Forman, L M Braswell and K W Miller
    Molecular Pharmacology December 1989, 36 (6) 874-880;
  • You have access
    Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    C W Lin, M W Holladay, R W Barrett, C A Wolfram, T R Miller, D Witte, J F Kerwin, F Wagenaar and A M Nadzan
    Molecular Pharmacology December 1989, 36 (6) 881-886;
  • You have access
    The psychotomimetic drug phencyclidine labels two high affinity binding sites in guinea pig brain: evidence for N-methyl-D-aspartate-coupled and dopamine reuptake carrier-associated phencyclidine binding sites.
    R B Rothman, A A Reid, J A Monn, A E Jacobson and K C Rice
    Molecular Pharmacology December 1989, 36 (6) 887-896;
  • You have access
    Apparent competition between ATP and the potassium channel opener RP 49356 on ATP-sensitive K+ channels of cardiac myocytes.
    D Thuringer and D Escande
    Molecular Pharmacology December 1989, 36 (6) 897-902;
  • You have access
    Serotonin depletion unmasks serotonergic component of [3H]dihydroalprenolol binding in rat brain.
    C A Stockmeier and K J Kellar
    Molecular Pharmacology December 1989, 36 (6) 903-911;
  • You have access
    Different modes of action of 3-amino-1-hydroxy-2-pyrrolidone (HA-966) and 7-chlorokynurenic acid in the modulation of N-methyl-D-aspartate-sensitive glutamate receptors.
    W Danysz, E Fadda, J T Wroblewski and E Costa
    Molecular Pharmacology December 1989, 36 (6) 912-916;
  • You have access
    H-7, a protein kinase C inhibitor, inhibits phorbol ester-caused ornithine decarboxylase induction but fails to inhibit phorbol ester-caused suppression of epidermal growth factor binding in primary cultured mouse epidermal cells.
    T Nakadate, S Yamamoto, E Aizu, K Nishikawa and R Kato
    Molecular Pharmacology December 1989, 36 (6) 917-924;
  • You have access
    Regulation of tyrosine hydroxylase activity in rat PC12 cells by neuropeptides of the secretin family.
    R Roskoski, L White, R Knowlton and L M Roskoski
    Molecular Pharmacology December 1989, 36 (6) 925-931;
  • You have access
    Metabolism of prazepam by rat liver microsomes: stereoselective formation and N-dealkylation of 3-hydroxyprazepam.
    X L Lu and S K Yang
    Molecular Pharmacology December 1989, 36 (6) 932-938;
  • You have access
    Mutagenicity of dimethyl heteroaromatic triazenes in the Ames test: the role of hydrophobicity and electronic effects.
    A J Shusterman, A K Debnath, C Hansch, G W Horn, F R Fronczek, A C Greene and S F Watkins
    Molecular Pharmacology December 1989, 36 (6) 939-944;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 36, Issue 6
1 Dec 1989
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Proteomic Analysis of GPCR Cell Biology
  • Phosphoproteomic Analysis of cAMP-Dependent Pathways
  • Phosphoproteomic Identification of Signaling Pathways
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Characterization of GRD and LCCH3 from Human Louse
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics